MIA team share learnings at two international conferences
Read more about how the MIA team continues to play a leading role in advancing the frontiers of melanoma research, presenting new findings at two major international oncology conferences - the AACR Annual Meeting in San Diego, and the EADO Congress in Prague.
Streamlining assessment of pathological response after neoadjuvant treatment
Neoadjuvant immunotherapy continues to transform outcomes for people with melanoma and other cancers. Two recent papers show that assessing pathological response after neoadjuvant immunotherapy can be both more efficient and more consistent, without compromising accuracy.
Poche Fellow in Melanoma and Surgical Oncology
Wollstonecraft, Sydney
Applications are open for the Poche Fellow in Melanoma and Surgical Oncology.
Melanoma March 2026 in pictures
See all the photos from our Melanoma March 2026 events, and download yours.
Biobank Technical Assistant
Contract/Temp, Wollstonecraft, Sydney
MIA is seeking a Biobank Technical Assistant to join its Biobank team.
Helen Godwin
Inspired by the work of Melanoma Institute Australia, Helen Godwin decided to support MIA through a bequest in her will. Her family recently visited MIA’s Translational Research Laboratory at Charles Perkins Centre (University of Sydney) and heard first-hand how Helen’s generosity will help support melanoma research projects, and ensure her legacy will make a lasting difference.
Karen Smith
Karen Smith is a Senior Clinical Data Manager at Melanoma Institute Australia (MIA), based at Westmead Hospital. Read on to learn what it means to be a clinical data manager, Karen's career journey and more!
Carina Paola Cornejo Páramo
Carina Paola Cornejo Páramo, who has a PhD in Bioinformatics, works as a Computational Data Scientist in the MIA Personalised Immunotherapy Platform team.
15 years of taking steps to save lives from melanoma
Melanoma March events are held across Australia during March to raise awareness about melanoma and support our life-saving melanoma research, which is also impacting other cancers.